Fig. 2From: Faecal calprotectin level for assessing endoscopic activity and predicting future clinical course in patients with moderately active ulcerative colitis undergoing granulomonocytapheresis: a prospective cohort studyThe change of endoscopic severity during the GMA treatment course. Mucosal healing was observed in 51 of the 158 patients (32%) with the Mayo endoscopic subscore (MES) 2 at entry vs none of the 26 patients with the MES 3 (P = 0.002)Back to article page